Antibody Cocktail Reduces COVID-19 Hospitalisation by 70% in Phase 3 Study
New data from a Phase 3 Study has shown that the investigational monoclonal antibody cocktail of casirivimab and imdevimab has
Read moreNew data from a Phase 3 Study has shown that the investigational monoclonal antibody cocktail of casirivimab and imdevimab has
Read moreCureVac intends to expand its COVID-19 vaccine candidate clinical trial in order to be able to determine efficacy for select
Read moreJohnson & Johnson announced today that the single-dose COVID-19 vaccine candidate developed by Janssen Pharmaceuticals showed 66% efficacy overall in
Read moreRoche revealed a new collaboration agreement with Moderna to use the Elecsys® Anti-SARS-CoV-2 S antibody assay in Moderna’s COVID-19 vaccine
Read moreAstraZeneca announced today, that interim trial data has shown it’s COVID-19 vaccine candidate AZD1222, developed in collaboration with the University
Read moreModerna announced its vaccine candidate against COVID-19 named mRNA-1273, has met Phase 3 study statistical criteria with a vaccine efficacy
Read morePfizer and BioNTech have announced their mRNA-based vaccine candidate for COVID-19, tested in a Phase 3 study involving 43,538 participants,
Read moreAstraZeneca has confirmed that the U.S. FDA has authorised the resumption of Phase III clinical trials of the COVID-19 AZD1222
Read moreEli Lilly and Company revealed on Monday, new efficiency and safety results from the Phase 2 SERENITY trial assessing Mirikizumab
Read moreAbbott declared the first patient has been enrolled in the DISTINCT study (Dorsal spInal cord STImulatioN vs mediCal management for
Read more